Advisors Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Advisors Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,989	Closed	-$69K	–	1547
2022 Q1	$69K	Sell	1,989 -408	-17%	-$12.2K	﹤0.01%	1384
2021 Q4	$70K	Sell	2,397 -22	-0.9%	-$681	﹤0.01%	1409
2021 Q3	$62K	Sell	2,419 -2	-0.1%	-$59	﹤0.01%	1346
2021 Q2	$85K	Sell	2,421 -9	-0.4%	-$351	﹤0.01%	1326
2021 Q1	$99K	Sell	2,430 -61	-2%	-$2.8K	﹤0.01%	1336
2020 Q4	$108K	Buy	2,491 +182	+8%	+$8.97K	﹤0.01%	1346
2020 Q3	$127K	Buy	2,309 +1,070	+86%	+$68K	﹤0.01%	1270
2020 Q2	$78K	Buy	+1,239	New	+$85K	﹤0.01%	1349

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Advisors Asset Management's GBT Position: Q2 2022 in Review

Advisors Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 1,989 shares — an estimated $69K sold.

Advisors Asset Management first reported a position in GBT in Q2 2020 and held it in 8 quarters. The position peaked at $127K in Q3 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

Advisors Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
Advisors Asset Management sold 1,989 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $69K.
Advisors Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 8 quarters.
Advisors Asset Management's Global Blood Therapeutics, Inc. position peaked at $127K in Q3 2020.
195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Advisors Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.